Implementing ordinance for facilitated access to treatments with medicinal cannabis in the consultation process
|

Implementing ordinance for facilitated access to treatments with medicinal cannabis in the consultation process

Bern, 25.08.2021 – At its meeting on August 25, 2021, the Federal Council opened the consultation on the implementation of the amendment to the Narcotics Act (BetmG) passed by Parliament. The amendment is intended to facilitate access to treatments with therapeutic cannabis. In the future, a prescription will no longer require the granting of an exceptional authorization from the Federal Office of Public Health (FOPH). Cannabis for consumption purposes, on the other hand, will continue to be prohibited.

Medical Cannabis & Cannabinoid Regulation 2021

Medical Cannabis & Cannabinoid Regulation 2021

Trends and Developments The current regulatory environment surrounding cannabinoid-based products in Switzerland is unfortunately still marked by a high degree of uncertainty, due both to vague legislative requirements and heterogenous, sometimes arbitrary, enforcement. However, with the rise of public awareness of the general benefits of the cannabis plant as a result of the cannabidiol (CBD)…

Products containing cannabidiol (CBD) – overview 21.04.2021 updates

Products containing cannabidiol (CBD) – overview 21.04.2021 updates

Implementation guide by the technical platform for delimitation issues of the FOPH, the FSVO and Swissmedic Products containing cannabidiol (CBD) are gaining popularity in Switzerland. Unlike THC (tetrahydrocannabinol), CBD is not subject to the Narcotics Act because it does not produce a comparable psychoactive effect. However, this does not mean that CBD can simply be…

TRAINING : Medical Cannabis «From plant to patient»

TRAINING : Medical Cannabis «From plant to patient»

Visit the new educational event Cannabis as medicine – «From plant to patient». Implementation: 01.05.2021 – 30.06.2021 (on demand until 31.12.2021) Type: e-learning + online workshop (05.06.2021) Costs: CHF 350 Accreditations (among others): FPH: 100, accredited for continuing education FPH Offizin (role 1.2) and continuing education. SDV: requested SGAIM: 4 points for workshop + up…

Applications for pilot trials on the non-medical use of cannabis can be submitted

Applications for pilot trials on the non-medical use of cannabis can be submitted

Starting from 15 May 2021, applications for pilot trials on the non-medical use of cannabis can be submitted to the FOPH. The aim of these trials is to provide a sound scientific basis for future decisions on the regulation of cannabis: Pilot trials on the controlled release of cannabis can start as early as May….

Radio: Hemp and Ecology – A local and sustainable medicine?

Radio: Hemp and Ecology – A local and sustainable medicine?

This week, in his radio programme “On va vers le beau“, Jonas Schneiter meets people who are working for sustainable solutions by developing different projects related to the production and transformation of hemp in Switzerland. Whether it is in the production of CBD, medicines, fashion or construction, he questions the role, the possibilities and the…

Medical Cannabis – Adoption of the Amendment to the Swiss Law on Narcotic Drugs (Cannabis-based medicines)

Medical Cannabis – Adoption of the Amendment to the Swiss Law on Narcotic Drugs (Cannabis-based medicines)

Bern, 08.03.2021 – The Council of States adopts the amendment to the Swiss Law on Narcotic Drugs and Psychotropic Substances. Access to medical cannabis will be made easier, as an exceptional authorisation from the FOPH for its use will no longer be required.

Crop Production in Switzerland- Hemp/Cannabis

Crop Production in Switzerland- Hemp/Cannabis

From 01.01.2021, the following applies: The agricultural production of hemp is allowed, provided it isn’t classified as a narcotic. All provisions of the seed legislation relating to the production and sale of hemp seed and seedlings are repealed (set of regulations 2020). For the agricultural production of hemp, the provisions of the plant health legislation…